[{"address1": "12278 Scripps Summit Drive", "city": "San Diego", "state": "CA", "zip": "92131", "country": "United States", "phone": "858 875 1800", "website": "https://www.fatetherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 181, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bahram  Valamehr M.B.A., Ph.D.", "age": 47, "title": "President, CEO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 676600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cindy R. Tahl J.D.", "age": 51, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 644600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Victor  Hong", "title": "Vice President of Corporate Development & Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Francis", "title": "Vice President Of Human Resources & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Henry", "age": 60, "title": "Senior Vice President of Clinical Operations", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tunde  Babalola", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yu  Cai", "title": "Head of Intellectual Property & Assistant General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.24, "open": 1.26, "dayLow": 1.23, "dayHigh": 1.34, "regularMarketPreviousClose": 1.24, "regularMarketOpen": 1.26, "regularMarketDayLow": 1.23, "regularMarketDayHigh": 1.34, "payoutRatio": 0.0, "beta": 2.415, "forwardPE": -0.7797619, "volume": 1350024, "regularMarketVolume": 1350024, "averageVolume": 2353683, "averageVolume10days": 2142740, "averageDailyVolume10Day": 2142740, "bid": 1.28, "ask": 1.33, "bidSize": 32, "askSize": 26, "marketCap": 150131232, "fiftyTwoWeekLow": 0.66, "fiftyTwoWeekHigh": 5.92, "priceToSalesTrailing12Months": 11.013956, "fiftyDayAverage": 1.0338, "twoHundredDayAverage": 2.3546, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -43677372, "profitMargins": 0.0, "floatShares": 100089391, "sharesOutstanding": 114604000, "sharesShort": 15586689, "sharesShortPriorMonth": 14571003, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.136, "heldPercentInsiders": 0.02239, "heldPercentInstitutions": 0.89075, "shortRatio": 7.87, "shortPercentOfFloat": 0.15529999, "impliedSharesOutstanding": 114604000, "bookValue": 2.798, "priceToBook": 0.46819153, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -186262000, "trailingEps": -1.64, "forwardEps": -1.68, "enterpriseToRevenue": -3.204, "enterpriseToEbitda": 0.247, "52WeekChange": -0.68957347, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 1.31, "targetHighPrice": 12.0, "targetLowPrice": 2.5, "targetMeanPrice": 6.55, "targetMedianPrice": 5.5, "recommendationMean": 2.42857, "recommendationKey": "buy", "numberOfAnalystOpinions": 10, "totalCash": 279068000, "totalCashPerShare": 2.435, "ebitda": -176576992, "totalDebt": 85265000, "quickRatio": 7.391, "currentRatio": 7.578, "totalRevenue": 13631000, "debtToEquity": 26.752, "revenuePerShare": 0.12, "returnOnAssets": -0.25812998, "returnOnEquity": -0.54213, "grossProfits": -104900000, "freeCashflow": -60771876, "operatingCashflow": -122874000, "revenueGrowth": 0.11, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -25.274729, "financialCurrency": "USD", "symbol": "FATE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1746228975, "regularMarketTime": 1746216001, "exchange": "NGM", "messageBoardId": "finmb_39268712", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 5.645156, "regularMarketPrice": 1.31, "shortName": "Fate Therapeutics, Inc.", "longName": "Fate Therapeutics, Inc.", "marketState": "CLOSED", "earningsTimestampEnd": 1747080000, "earningsCallTimestampStart": 1715288400, "earningsCallTimestampEnd": 1715288400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.64, "epsForward": -1.68, "epsCurrentYear": -1.458, "priceEpsCurrentYear": -0.8984911, "fiftyDayAverageChange": 0.27619994, "fiftyDayAverageChangePercent": 0.2671696, "twoHundredDayAverageChange": -1.0446, "twoHundredDayAverageChangePercent": -0.44364226, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1380634200000, "postMarketChangePercent": -3.05343, "postMarketPrice": 1.27, "postMarketChange": -0.04, "regularMarketChange": 0.06999993, "regularMarketDayRange": "1.23 - 1.34", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2353683, "fiftyTwoWeekLowChange": 0.6499999, "fiftyTwoWeekLowChangePercent": 0.9848483, "fiftyTwoWeekRange": "0.66 - 5.92", "fiftyTwoWeekHighChange": -4.61, "fiftyTwoWeekHighChangePercent": -0.7787162, "fiftyTwoWeekChangePercent": -68.957344, "earningsTimestamp": 1741208460, "earningsTimestampStart": 1746648000, "displayName": "Fate Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]